Céline Gavoille

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Medicine, Oncology, Molecular Oncology +14

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Alain R. Thierry, Safia El Messaoudi, Caroline Mollévi et al. · Annals of Oncology · 2017 · 114 citations

Medicine, Molecular Biology, Oncology +17

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

Lisa Belin, Maud Kamal, Cécile Mauborgne et al. · Annals of Oncology · 2016 · 84 citations · Full text

Medicine, Oncology, Pharmacology +15

Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial

Christophe Le Tourneau, Xavier Paolettí, Nicolas Servant et al. · British Journal of Cancer · 2014 · 70 citations · Full text

Medicine, Oncology, Pathology +15